Donna Zubek's Email Addresses & Phone Numbers

📖 Summary

Pioneers in new and uncertain territories with a unique combination of science, marketing and leadership. Former hospital nurse with MBA. Versatile, innovative Global & US Strategic Marketer, New Products'​ Planner, Business Development leader with launch and corporate licensing expertise. Talent generating robust business case valuations, including for rare diseases and commercial and branding strategies and tactics. Recognized as a highly collaborative positive change agent. Effective partner with R & D, external alliances and commercial team. Expertise in lifecycle management, portfolio prioritization, forecasting, digital promotions, marketing research. Diverse therapeutic area biotech & pharmaceutical experience: pipeline new products marketing to product launch to mature brand HCP and consumer inline marketing and consulting. Core skills in brand strategy development, positioning, branding and driving consensus on cross functional teams. Disease knowledge: Dementia/Alzheimer's Disease, oncology pain, neurology (inc. rare diseases), psychiatry, diabetes, cardiovascular, GI, immunology, others. Consultant to numerous biotechs (Genentech, Amgen, Tularik, Neurex, HGS). Specialties: Prelaunch Global & Prelaunch US Brand Builder Robust Business Development Reviews Life Cycle Management Positioning/Messaging Branding -Trade name/Trade Dress Professional and Consumer Promotions Rare Disease assessments Segmentation Portfolio prioritization Differentiation Marketing research HCP/consumer digital marketing promotionsUS Brand Lead - Nabiximols @ From March 2015 to Present (10 months) Assoc. Director, US Marketing @ Evidence-based collaborative builder of new commercial opportunities and core strategic elements (vision, positioning, levers, messaging, branding, TPP, LCM) for PhIII US & global brands (nabiximols – cancer pain, MS ; AE58054 – Alzheimer’s; Launched Abilify Maintena –Schiz. Brex –MDD, rare diseases, LCM. Close collaboration with R&D, clinical pharmacology, regulatory, marketing research, payer, HEOR, medical, policy to develop launch scientific communications and commercial plans. • Persuaded senior leadership to execute two business development evaluations for new CNS conditions within corporate alliance • Commercial risk evaluation convinced leadership to start a pivotal MDD trial • In partnership with clinical development and HEOR/MA, influenced alliance to include a critical caregiver dependency scales into the PhIII Alzheimer’s program * Successfully launched a novel long acting antipsychotic and trained field staff in record time * Published/presented >15 novel HEOR focused posters/manuscripts at critical venues From August 2014 to March 2015 (8 months) Assoc.Director, Global New Products Marketing @ From June 2013 to August 2014 (1 year 3 months) Medical Affairs @ From October 2011 to May 2013 (1 year 8 months) Director, US New Products Marketing; Brand Marketer @ Led US cross functional commercial strategy teams for high profile, multi-billion dollar diabetes and CNS brands in pipeline, inc. rare diseases. Responsible for overall commercial prelaunch strategic and tactical Brand Plans, including; branding elements, publication planning, KOL activities, segmentation analyses, forecasts, advocacy, LCM, managed markets, marketing research, health outcomes initiatives, etc. Produced targeted analytical marketing recommendations for BD/licensing opportunities in close alignment with R & D. Directed professional/consumer promotion with P&L accountability. From January 2005 to December 2010 (6 years) Director, Global CNS Therapy Area Marketing @ Global lead on Alzheimer's, Parkinson's Disease and other neurology drugs in development. Generated multi-country aligned marketing plans in US, Europe, Asia, ROW. Assessed and recommended licensing opportunities. From April 2004 to December 2004 (9 months) Director Corporate Licensing @ Proactive identification of key commercial assumptions & initial financial models (NPV) for complex global and US in-licensing projects, including rare diseases. Generated sales forecasts, structured deal terms, reviewed intellectual control (IP). Provided creative, actionable terms and business related analyses likely to impact future revenue streams. From September 1999 to November 2003 (4 years 3 months) Owner @ Marketing planning, strategic marketing, business development and marketing research consultant to various biotechnology and pharmaceutical companies. Hired and managed a team of professionals. Responsible for P & L. From July 1995 to August 1999 (4 years 2 months) Marketing Analysis Manager, Senior International Marketing Researcher, Clinical Research Associate @ Generated comprehensive, strategic, global new product position papers to advance Ph I-III pipeline compounds including rare diseases. Collaborated on the prioritization of 33 internal development compounds on commercial attractiveness, preclinical/clinical viability and regulatory risk. Marketing Researcher for international projects, managed clinical trials. From 1986 to 1995 (9 years) MBA, Marketing @ Golden Gate University From 1992 to 1994 BSN, Nursing @ Syracuse University From 1978 to 1982 HSD @ Abington Friends School From 1974 to 1978 Donna Zubek is skilled in: Diabetes, Managed Care, Pharmaceutical Industry, Global Marketing, Cross-functional Team Leadership, Product Launch, Market Access, Strategy, Portfolio Management, Segmentation, Biotechnology, Urology, Consulting, Sales Effectiveness, Cardiology